Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

Mochi Health Corp, Fella Health and Delilah, Willow Health Services, and Henry Meds are the named companies in Eli Lilly’s ...

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth ...

In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...

Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling ...

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly’s weight-loss drug Zepbound and its ...

Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...

Three notes: 1. While the agency is not currently moving forward with a proposal… Mounjaro (tirzepatide) led to greater weight loss and better glucose control than high doses of Trulicity ...

Advt The recent launch of Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight management and type 2 diabetes by pharma giant Eli Lilly, has increased acceptance of weight loss ...

Mounjaro, which uses the active ingredient tirzepatide, is FDA approved for type 2 diabetes. A newer version of the drug, Zepbound, which uses the same active ingredient, was approved in 2023 ...

Currently, semaglutide accounts for 69% of the market at '397 crore, up from '11 crore in March 2022. The recent launch of Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...